Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 20, 2019 - Issue 1
Submit an article Journal homepage
2,067
Views
7
CrossRef citations to date
0
Altmetric
Editorial

What is the best pharmacotherapeutic strategy for HER-2 positive breast cancer?

Gaia GiannoneMedical Oncology, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy;Medical School, University of Turin, Turin, ItalyView further author information
,
Andrea MilaniInvestigational and Clinical Oncology, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, ItalyView further author information
,
Elena GeunaInvestigational and Clinical Oncology, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, ItalyView further author information
,
Danilo GaliziaInvestigational and Clinical Oncology, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, ItalyView further author information
,
Federica BielloInvestigational and Clinical Oncology, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, ItalyView further author information
&
Filippo MontemurroInvestigational and Clinical Oncology, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, ItalyCorrespondence[email protected]
View further author information
Pages 5-9 | Received 15 Jul 2018, Accepted 30 Oct 2018, Published online: 06 Nov 2018

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Filippo Montemurro, Imperia Nuzzolese & Riccardo Ponzone. (2020) Neoadjuvant or adjuvant chemotherapy in early breast cancer?. Expert Opinion on Pharmacotherapy 21:9, pages 1071-1082.
Read now

Articles from other publishers (6)

Qitong Wu & Dipali Sharma. (2023) Autophagy and Breast Cancer: Connected in Growth, Progression, and Therapy. Cells 12:8, pages 1156.
Crossref
Hui-Hsia HsiehTien-Yuan WuChi-Hua ChenYu-Hung KuoMann-Jen Hour. (2023) Survival outcomes of beta-blocker usage in HER2-positive advanced breast cancer patients: a retrospective cohort study. Therapeutic Advances in Drug Safety 14.
Crossref
Zhen Zhang, Luoyan Zhang, Guoxiang Yu, Zhigang Sun, Tiantian Wang, Xingsong Tian, Xuening Duan & Chi Zhang. (2020) Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer. Cancer Chemotherapy and Pharmacology 86:6, pages 761-772.
Crossref
Salvatore Del Prete, Liliana Montella, Grazia Arpino, Giuseppe Buono, Carlo Buonerba, Pasquale Dolce, Olga Fiorentino, Maria Aliberti, Antonio Febbraro, Clementina Savastano, Giuseppe Colantuoni, Ferdinando Riccardi, Angela Ruggiero, Sabino De Placido & Michele Orditura. (2020) Second line trastuzumab emtansine following horizontal dual blockade in a real-life setting. Oncotarget 11:22, pages 2083-2091.
Crossref
Elena Geuna, Pasquale Lombardi, Rossella Martinello, Davide Garino, Alessandro Bonzano, Danilo Galizia, Annamaria Nuzzo, Paola Berchialla, Paolo Becco, Monica Mangioni, Lorena De Zarlo & Filippo Montemurro. (2020) Treatment with Beta-Blockers and ACE-Inhibitors in Breast Cancer Patients Receiving Adjuvant Trastuzumab-Based Therapy and Developing Mild Cardiac Toxicity: A Prospective Study. Cancers 12:2, pages 327.
Crossref
Mingli Han, Jianguo Hu, Pengwei Lu, Hui Cao, Chao Yu, Xiangke Li, Xueke Qian, Xue Yang, Yunqing Yang, Na Han, Dongwei Dou, Fan Zhang, Mulin Ye, Changcheng Yang, Yuanting Gu & Huaying Dong. (2020) RETRACTED ARTICLE: Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer. Cell Death & Disease 11:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.